Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Kaltrol - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Kaltrol

Approved

STANDARD

Kaltrol

Zhejiang Tianrui Pharmaceutical Co., Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 8146e88c84653fc9
Company: Zhejiang Tianrui Pharmaceutical Co., Ltd.
Type: Standard

Approval Details

Approval Id: 8146e88c84653fc9
Drug Approval Philippines Name: Kaltrol
Product Name: Kaltrol
Registration Number: DR-XY42200
Brand Name: Kaltrol
Generic Name: Potassium Chloride
Dosage Form: Solution For Injection
Dosage Strength: 150mg/mL (2meq/mL)
Manufacturer: Zhejiang Tianrui Pharmaceutical Co., Ltd.
Importer: Global Pharmatrade
Distributor: Global Pharmatrade
Issuance Date: 26 July 2023
Expiry Date: 10 July 2028
Pharmacologic Category: Electrolyte or IV Additive Solution Solution
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

8146e88c84653fc9

Type

Standard

Back to Philippines FDA Approvals